-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the rapid development of China's economy and the improvement of people's living standards, while China's demand for drugs continues to increase, the development of China's pharmaceutical equipment industry has begun to accelerate, and the market scale is also growing
.
According to data, the market size of China's pharmaceutical equipment industry in 2020 will be 21.
581 billion yuan, a year-on-year increase of 7.
26%
.
In 2021, the scale of China's pharmaceutical equipment market is expected to reach about 40 billion yuan
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The industry believes that under the normal equipment renewal and technological transformation of pharmaceutical companies, the demand for pharmaceutical machines will form an increasingly significant market
.
But at the same time, pharmaceutical equipment companies also need to strengthen their professionalism in the industry, improve product quality and safety, strictly supervise, and continuously improve their own product quality management level
.
It is reported that in November, the "Notice on the Implementation Plan for Promoting the High-quality Development of the Original Science and Technology Industry" clearly stated that it is necessary to promote cross-field resource sharing and cooperation, and strengthen enterprises in bioengineering, fine chemicals, hazardous waste disposal, and pharmaceutical equipment.
Collaborate with API companies to improve the modernization level of the industrial chain
.
It is worth noting that, affected by the current series of policies in the pharmaceutical industry and the pharmaceutical industry, the industry expects that in addition to the above development trends, the future development of the entire pharmaceutical equipment industry will accelerate in three directions
.
High-endization In the context of the continuous expansion of the domestic pharmaceutical equipment industry and the relatively complete product range, in order to meet the increasing demand of pharmaceutical companies and increase the breakthrough of their own performance, many pharmaceutical equipment companies are still accelerating their entry into the high-end market.
.
It is understood that Chutian Technology is one of China's very active companies to enter the high-end pharmaceutical equipment market
.
According to its semi-annual report, Chutian Technology is now able to provide a variety of highly intelligent, cost-effective biopharmaceutical equipment
.
Judging from the fact that many pharmaceutical equipment companies are making efforts to build higher-end pharmaceutical equipment, and their performance has begun to improve, the overall business model of the domestic pharmaceutical equipment industry is continuously upgrading; competitiveness in the high-end market is also constantly improving
.
In this regard, the industry believes that under this trend, through the continuous development and innovation of pharmaceutical machinery companies in the future, domestic pharmaceutical equipment companies will gradually become a segment of China's high-end manufacturing, and their performance will continue to grow; in addition, the industry will also The cyclical attribute is gradually faded to usher in long-term growth
.
Intelligentization As the world is entering a period of rapid development of the digital economy, new technologies, new formats, and new platforms such as 5G, artificial intelligence, and smart cities are booming.
The development direction of China's manufacturing industry, including the pharmaceutical equipment industry, has also begun to become intelligent.
The direction accelerates
.
It is understood that the current level of automation and intelligence of domestic pharmaceutical equipment is getting higher and higher, and pharmaceutical equipment companies have gradually transformed from a single product supplier to a supplier that can provide users with professional pharmaceutical equipment solutions.
The types of pharmaceutical production equipment products are becoming more diverse, and the specifications are becoming more complete
.
The industry predicts that in the future, as pharmaceutical companies continue to promote the development of the high-end pharmaceutical preparation production industry, the domestic pharmaceutical industry's demand will continue to increase
.
If pharmaceutical equipment companies want to meet these needs, they need to continue to innovate to further enhance the level of intelligence for their products and create more value for pharmaceutical companies
.
However, it should be noted that at present, most of China's pharmaceutical equipment companies are still at the industry 3.
0 level and are not yet mature in terms of professionals, data, standards, etc.
Therefore, in the future in the field of intelligence, related companies will need to increase investment and accelerate exploration , Innovation
.
Internationalization Under the background of severe homogeneity of products in the domestic pharmaceutical machinery market and increasingly fierce market competition, large pharmaceutical equipment companies are exploring overseas markets in order to seek new growth points
.
It is worth noting that since 2020, many domestic pharmaceutical companies have received some overseas business, which has brought new breakthroughs to their international business
.
For example, in 2020, the company's overseas revenue will account for about 20%
.
At present, the company has more than 10,000 pharmaceutical equipment and pharmaceutical manufacturing systems serving more than 1,000 large pharmaceutical companies in more than 40 countries and regions around the world
.
In addition, Chutian Technology's 2020 annual report also shows that overseas performance has achieved steady growth, and foreign revenue has increased by 6.
63% year-on-year.
.
Among them, ROMACO achieved a net profit of RMB 73,722,600 for the year, exceeding the performance target with a completion rate of 133.
73%
.
It is worth mentioning that for the international layout, Chutian Technology also stated that in the next 3-5 years, the company plans to maintain an annual increase of 10%-20% in its export business.
It accounts for 40%-50% of total revenue
.
On the whole, accelerating the expansion of international markets has now become a distinct trend in the domestic pharmaceutical equipment industry
.
In the future, it is expected that more and more pharmaceutical machinery companies will also embark on the road of expanding the international market under favorable policies
.
.
According to data, the market size of China's pharmaceutical equipment industry in 2020 will be 21.
581 billion yuan, a year-on-year increase of 7.
26%
.
In 2021, the scale of China's pharmaceutical equipment market is expected to reach about 40 billion yuan
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The industry believes that under the normal equipment renewal and technological transformation of pharmaceutical companies, the demand for pharmaceutical machines will form an increasingly significant market
.
But at the same time, pharmaceutical equipment companies also need to strengthen their professionalism in the industry, improve product quality and safety, strictly supervise, and continuously improve their own product quality management level
.
It is reported that in November, the "Notice on the Implementation Plan for Promoting the High-quality Development of the Original Science and Technology Industry" clearly stated that it is necessary to promote cross-field resource sharing and cooperation, and strengthen enterprises in bioengineering, fine chemicals, hazardous waste disposal, and pharmaceutical equipment.
Collaborate with API companies to improve the modernization level of the industrial chain
.
It is worth noting that, affected by the current series of policies in the pharmaceutical industry and the pharmaceutical industry, the industry expects that in addition to the above development trends, the future development of the entire pharmaceutical equipment industry will accelerate in three directions
.
High-endization In the context of the continuous expansion of the domestic pharmaceutical equipment industry and the relatively complete product range, in order to meet the increasing demand of pharmaceutical companies and increase the breakthrough of their own performance, many pharmaceutical equipment companies are still accelerating their entry into the high-end market.
.
It is understood that Chutian Technology is one of China's very active companies to enter the high-end pharmaceutical equipment market
.
According to its semi-annual report, Chutian Technology is now able to provide a variety of highly intelligent, cost-effective biopharmaceutical equipment
.
Judging from the fact that many pharmaceutical equipment companies are making efforts to build higher-end pharmaceutical equipment, and their performance has begun to improve, the overall business model of the domestic pharmaceutical equipment industry is continuously upgrading; competitiveness in the high-end market is also constantly improving
.
In this regard, the industry believes that under this trend, through the continuous development and innovation of pharmaceutical machinery companies in the future, domestic pharmaceutical equipment companies will gradually become a segment of China's high-end manufacturing, and their performance will continue to grow; in addition, the industry will also The cyclical attribute is gradually faded to usher in long-term growth
.
Intelligentization As the world is entering a period of rapid development of the digital economy, new technologies, new formats, and new platforms such as 5G, artificial intelligence, and smart cities are booming.
The development direction of China's manufacturing industry, including the pharmaceutical equipment industry, has also begun to become intelligent.
The direction accelerates
.
It is understood that the current level of automation and intelligence of domestic pharmaceutical equipment is getting higher and higher, and pharmaceutical equipment companies have gradually transformed from a single product supplier to a supplier that can provide users with professional pharmaceutical equipment solutions.
The types of pharmaceutical production equipment products are becoming more diverse, and the specifications are becoming more complete
.
The industry predicts that in the future, as pharmaceutical companies continue to promote the development of the high-end pharmaceutical preparation production industry, the domestic pharmaceutical industry's demand will continue to increase
.
If pharmaceutical equipment companies want to meet these needs, they need to continue to innovate to further enhance the level of intelligence for their products and create more value for pharmaceutical companies
.
However, it should be noted that at present, most of China's pharmaceutical equipment companies are still at the industry 3.
0 level and are not yet mature in terms of professionals, data, standards, etc.
Therefore, in the future in the field of intelligence, related companies will need to increase investment and accelerate exploration , Innovation
.
Internationalization Under the background of severe homogeneity of products in the domestic pharmaceutical machinery market and increasingly fierce market competition, large pharmaceutical equipment companies are exploring overseas markets in order to seek new growth points
.
It is worth noting that since 2020, many domestic pharmaceutical companies have received some overseas business, which has brought new breakthroughs to their international business
.
For example, in 2020, the company's overseas revenue will account for about 20%
.
At present, the company has more than 10,000 pharmaceutical equipment and pharmaceutical manufacturing systems serving more than 1,000 large pharmaceutical companies in more than 40 countries and regions around the world
.
In addition, Chutian Technology's 2020 annual report also shows that overseas performance has achieved steady growth, and foreign revenue has increased by 6.
63% year-on-year.
.
Among them, ROMACO achieved a net profit of RMB 73,722,600 for the year, exceeding the performance target with a completion rate of 133.
73%
.
It is worth mentioning that for the international layout, Chutian Technology also stated that in the next 3-5 years, the company plans to maintain an annual increase of 10%-20% in its export business.
It accounts for 40%-50% of total revenue
.
On the whole, accelerating the expansion of international markets has now become a distinct trend in the domestic pharmaceutical equipment industry
.
In the future, it is expected that more and more pharmaceutical machinery companies will also embark on the road of expanding the international market under favorable policies
.